World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: IRCT
Last refreshed on: 22 February 2018
Main ID:  IRCT2014122610279N5
Date of registration: 2015-02-24
Prospective Registration: No
Primary sponsor: Health Ministry Drug and Pharmacy General Management
Public title: Swaddle and/or sucrose role in the pain control during eye examination
Scientific title: Comparing the effect of swaddle and sucrose combination with unique effect of both swaddle, sucrose or placebo on the control of pain secondary to retinopathy of prematurity examination of premature neonates
Date of first enrolment: 2010-12-01
Target sample size: 83
Recruitment status: Complete
URL:  http://en.irct.ir/trial/10745
Study type:  interventional
Study design:  Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Factorial, Purpose: Prevention, Other design features: Neonates were divided by four group; group 1(Placebo group): Neonates who were given distilled water 2 minutes before the procedure (n= 21); group 2: Neonates who were swaddled 15 minutes before the procedure (n= 20); group 3: Neonates who were given 0.6 ml 24% sucrose 2 minutes before the procedure (n= 22); group 4: Neonates who were swaddled 15 minutes before the procedure and who were given 0.6 ml 24% sucrose 2 minutes before the procedure (n= 20). Neonates were randomly assigned to one of four groups, using a computer generated randomization programme. The packed colorless study solutions were provided by the pharmacy in sealed envelopes to the patient’s nurse 3 minutes before the examination. The nurse, ophthalmologist, and investigators and the parents were blinded to the group assignment. Tropicamide (0.5%) and fenilefrin HCL were dropp  
Phase:  3
Countries of recruitment
Turkey
Contacts
Name: Derya Benzer   
Address:  No:3-4, Dr. Burhanettin Üstünel Sokak., Zeynep Kamil Mah. 34668 Istanbul Turkey
Telephone: 0090 216 391 06 80
Email: dbenzer@yahoo.com
Affiliation:  Zeynep Kamil Maternity and Children's Education and Training Hospital
Name: Guner Karatekin   
Address:  No:3-4, Dr. Burhanettin Üstünel Sokak., Zeynep Kamil Mah. 34668 Istanbul Turkey
Telephone: 0090 216 391 06 80
Email: gunerkaratekin@yahoo.com
Affiliation:  Zeynep Kamil Maternity and Children's Education and Training Hospital
Key inclusion & exclusion criteria
Inclusion criteria: Inclusion criteria; 1. Premature neonates who underwent first retinopathy of prematurity examination. Exclusion criteria; 1. Invasive or noninvasive mechanical ventilation therapy during retinopathy of prematurity examination. 2. Neonates who take analgesia, sedative medicine. 3. Asphyxia 4. Intraventricular hemorrhage 5. Neonates who were resuscitated 6. Neonates who had congenital anomaly
Exclusion criteria:

Age minimum: 28 days
Age maximum: 2 months
Gender: Both
Health Condition(s) or Problem(s) studied
Retinopathy of prematurity.
Retinopathy of prematurity
Retinopathy of prematurity
Intervention(s)
Intervention 1: Neonates who were given distilled water 2 minutes before the procedure. Intervention 2: Neonates who were swaddled 15 minutes before the procedure. Intervention 3: Neonates who were given 0.6 ml 24% sucrose 2 minutes before the procedure. Intervention 4: Neonates who were swaddled 15 minutes before the procedure and who were given 0.6 ml 24% sucrose 2 minutes before the procedure.
Neonates who were swaddled 15 minutes before the procedure
Placebo
Neonates who were given 0.6 ml 24% sucrose 2 minutes before the procedure.
Neonates who were swaddled 15 minutes before the procedure and who were given 0.6 ml 24% sucrose 2 minutes before the procedure.
Neonates who were given distilled water 2 minutes before the procedure
Primary Outcome(s)
Premature infant pain scale (PIPP). Timepoint: 30th and 60th second, 2nd minute for both eye examination, also 4th minute for right eye examination. Method of measurement: Video records.
Secondary Outcome(s)
Frequency of bradycardia (<100 bpm). Timepoint: 30th and 60th second, 2nd minute for both eye examination, also 4th minute for right eye examination. Method of measurement: Video records.
Frequency of tachycardia (>180 bpm). Timepoint: 30th and 60th second, 2nd minute for both eye examination, also 4th minute for right eye examination. Method of measurement: Video records.
Degree of cry. Timepoint: 30th and 60th second, 2nd minute for both eye examination, also 4th minute for right eye examination. Method of measurement: Video records.
Crying time. Timepoint: 30th and 60th second, 2nd minute for both eye examination, also 4th minute for right eye examination. Method of measurement: Video records.
Desaturation (<85% for 10 seconds). Timepoint: 30th and 60th second, 2nd minute for both eye examination, also 4th minute for right eye examination. Method of measurement: Video records.
Secondary ID(s)
Source(s) of Monetary Support
Health Ministry Drug and Pharmacy General Management
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date:
Contact:
Zeynep Kamil Maternity and Children's Education and Training Hospital Ethical Committee
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history